Identification of guanine nucleotide-binding protein γ-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling

Demokan,Semra; Chuang,Alice  Y.; Chang,Xiaofei; Khan,Tanbir; Smith,Ian  M.; Pattani,Kavita M.; Dasgupta,Santanu; Begum,Shahnaz; Khan,Zubair; Liegeois,Nanette  J.; Westra,William  H.; Sidransky,David; Koch,Wayne; Califano,Joseph  A.

doi:10.3892/ijo.2013.1808

Identification of guanine nucleotide-binding protein γ-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling

Authors:
- Semra Demokan
- Alice Y. Chuang
- Xiaofei Chang
- Tanbir Khan
- Ian M. Smith
- Kavita M. Pattani
- Santanu Dasgupta
- Shahnaz Begum
- Zubair Khan
- Nanette J. Liegeois
- William H. Westra
- David Sidransky
- Wayne Koch
- Joseph A. Califano
View Affiliations

Affiliations: Department of Basic Oncology, Oncology Institute, Istanbul University, Capa, 34093 Istanbul, Turkey, Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD, USA, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA, Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Published online on: February 6, 2013 https://doi.org/10.3892/ijo.2013.1808
Pages: 1427-1436

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Silencing of tumor suppressor genes plays a vital role in head and neck carcinogenesis. Aberrant hypermethylation in the promoter region of some known or putative tumor suppressor genes occurs frequently during the development of various types of cancer including head and neck squamous cell carcinoma (HNSCC). In this study we used an expanded mRNA expression profiling approach followed by microarray expression analysis to identify epigenetically inactivated genes in HNSCC. Two HNSCC cell lines were treated with 5-aza-2'-deoxycytidine followed by microarray analysis to identify epigenetically silenced genes in HNSCC. We found 1,960, 614 and 427 genes were upregulated in the HNSCC cell lines JHU-012, JHU-011 and the combination of both cell lines, respectively. HNSCC tumor and normal mucosal samples were used for gene profiling by a 47K mRNA gene expression array and we found 7,140 genes were downregulated in HNSCC tumors compared to normal mucosa, as determined by microarray analysis, and were integrated with cell line data. Integrative analysis defined 126 candidate genes, of which only seven genes showed differential methylation in tumors and no methylation in normal mucosa after bisulfite sequencing. Following validation by QMSP, one gene, guanine nucleotide-binding protein γ-7 (GNG7), was confirmed to be highly methylated in tumors and unmethylated in normal mucosal and salivary rinse samples demonstrating cancer-specific methylation in HNSCC tissues. TXNIP and TUSC2 were partially methylated in tumors and normal salivary rinses but unmethylated in normal mucosa. We concluded that GNG7 is a highly specific promoter methylated gene associated with HNSCC. In addition, TXNIP and TUSC2 are also potential biomarkers for HNSCC.

View Figures

View References

1	Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar
2	Fearon ER and Vogelstein B: A genetic model of colorectal tumorigenesis. Cell. 61:759–767. 1990. View Article : Google Scholar : PubMed/NCBI
3	Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP: Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 72:141–196. 1998. View Article : Google Scholar : PubMed/NCBI
4	Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T and Cairns P: Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res. 10:6189–6193. 2004. View Article : Google Scholar : PubMed/NCBI
5	Leonhardt H and Cardoso MC: DNA methylation, nuclear structure, gene expression and cancer. J Cell Biochem. 35(Suppl): S78–S83. 2000. View Article : Google Scholar
6	Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
7	Yamashita K, Upadhyay S, Osada M, et al: Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell. 2:485–495. 2002. View Article : Google Scholar : PubMed/NCBI
8	Bernard PS and Wittwer CT: Real-time PCR technology for cancer diagnostics. Clin Chem. 48:1178–1185. 2002.PubMed/NCBI
9	Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C and Shibata D: MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28:E322000. View Article : Google Scholar : PubMed/NCBI
10	Cottrell SE and Laird PW: Sensitive detection of DNA methylation. Ann NY Acad Sci. 983:120–130. 2003. View Article : Google Scholar : PubMed/NCBI
11	Jerónimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG and Sidransky D: Quantitation of GSTP₁ methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst. 93:1747–1752. 2001.
12	Tokumaru Y, Yamashita K, Osada M, et al: Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Cancer Res. 64:5982–5987. 2004. View Article : Google Scholar : PubMed/NCBI
13	Li C and Wong WH: Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc Natl Acad Sci USA. 98:31–36. 2001. View Article : Google Scholar : PubMed/NCBI
14	Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 98:5116–5121. 2001. View Article : Google Scholar : PubMed/NCBI
15	Carvalho AL, Jeronimo C, Kim MM, et al: Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res. 14:97–107. 2008. View Article : Google Scholar : PubMed/NCBI
16	Li LC and Dahiya R: MethPrimer: designing primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002. View Article : Google Scholar : PubMed/NCBI
17	Giefing M, Arnemann J, Martin-Subero JI, et al: Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines. Br J Haematol. 142:916–924. 2008. View Article : Google Scholar : PubMed/NCBI
18	Ray K, Kunsch C, Bonner LM and Robishaw JD: Isolation of cDNA clones encoding eight different human G protein gamma subunits, including three novel forms designated the gamma-4, gamma-10, and gamma-11 subunits. J Biol Chem. 270:21765–21771. 1995. View Article : Google Scholar
19	Shibata K, Mori M, Tanaka S, Kitano S and Akiyoshi T: Identification and cloning of human G-protein gamma 7, down-regulated in pancreatic cancer. Biochem Biophys Res Commun. 246:205–209. 1998. View Article : Google Scholar : PubMed/NCBI
20	Ohta M, Mimori K, Fukuyoshi Y, et al: Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer. Br J Cancer. 98:410–417. 2008. View Article : Google Scholar : PubMed/NCBI
21	Wang M, Gong B, Li Y and Wang Y: Human G-protein gamma 7 in extrahepatic cholangiocarcinoma and its clinicopathological significance. Hematol Oncol Stem Cell Ther. 3:66–70. 2010. View Article : Google Scholar : PubMed/NCBI
22	Wollman EE, d’Auriol L, Rimsky L, et al: Cloning and expression of a cDNA for human thioredoxin. J Biol Chem. 263:15506–15512. 1988.PubMed/NCBI
23	Meng L, Wong JH, Feldman LJ, Lemaux PG and Buchanan BB: A membrane-associated thioredoxin required for plant growth moves from cell to cell, suggestive of a role in intercellular communication. Proc Natl Acad Sci USA. 107:3900–3905. 2010. View Article : Google Scholar : PubMed/NCBI
24	Nishiyama A, Matsui M, Iwata S, et al: Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem. 274:21645–21650. 1999. View Article : Google Scholar : PubMed/NCBI
25	Han SH, Jeon JH, Ju HR, et al: VDUP1 upregulated by TGF-beta1 and 1,25-dihydroxyvitamin D₃ inhibits tumor cell growth by blocking cell-cycle progression. Oncogene. 22:4035–4046. 2003.PubMed/NCBI
26	Fischer WH and Schubert D: Characterization of a novel platelet-derived growth factor-associated protein. J Neurochem. 66:2213–2216. 1996. View Article : Google Scholar : PubMed/NCBI
27	Kondo M, Ji L, Kamibayashi C, et al: Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells. Oncogene. 20:6258–6262. 2001. View Article : Google Scholar : PubMed/NCBI
28	Ivanova AV, Ivanov SV, Prudkin L, et al: Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects. Mol Cancer. 8:912009. View Article : Google Scholar : PubMed/NCBI
29	Zhou YB, Huang ZX, Ren CP, Zhu B and Yao KT: Screening and preliminary analysis of the apoptosis- and proliferation-related genes in nasopharyngeal carcinoma. Nan Fang Yi Ke Da Xue Xue Bao. 29:645–647. 2009.(In Chinese).
30	Lerman MI and Minna JD: The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The international lung cancer chromosome 3p213 tumor suppressor gene consortium. Cancer Res. 60:6116–6133. 2000.
31	Uno F, Sasaki J, Nishizaki M, et al: Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells. Cancer Res. 64:2969–2976. 2004. View Article : Google Scholar : PubMed/NCBI
32	Prudkin L, Behrens C, Liu DD, et al: Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer. Clin Cancer Res. 14:41–47. 2008. View Article : Google Scholar : PubMed/NCBI
33	Hennessey PT, Ochs MF, Mydlarz WW, Hsueh W, Cope L, Yu W and Califano JA: Promoter methylation in head and neck squamous cell carcinoma cell lines is significantly different than methylation in primary tumors and xenografts. PLoS One. 6:e205842011. View Article : Google Scholar : PubMed/NCBI